This inventor holds 1 USPTO granted patent. Top assignee: Cell Id Pte Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Seung-Phil Shin: Innovator in Coronavirus Vaccine Development
Introduction
Seung-Phil Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines for infectious diseases. His innovative work has garnered attention in the scientific community.
Latest Patents
Seung-Phil Shin holds a patent for a groundbreaking invention titled "Novel Coronavirus Recombinant Spike Protein, Polynucleotide Encoding Same, Vector Comprising Polynucleotide, and Vaccine for Preventing or Treating Coronavirus Infection, Comprising Vector." This patent represents a crucial advancement in the fight against coronavirus infections.
Career Highlights
Shin is currently associated with Cell ID Pte Ltd, where he continues to work on innovative solutions in the field of biotechnology. His expertise and dedication have positioned him as a key figure in vaccine research and development.
Collaborations
Throughout his career, Seung-Phil Shin has collaborated with notable colleagues, including Chang-Yuil Kang and Kwang-Soo Shin. These partnerships have enhanced the scope and impact of his research efforts.
Conclusion
Seung-Phil Shin's contributions to vaccine development, particularly in relation to coronavirus, highlight his role as an influential inventor in the biotechnology sector. His work continues to pave the way for advancements in public health and disease prevention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile